Standout Papers

The spike protein of SARS-CoV — a target for vaccine and therapeutic development 2009 2026 2014 2020 1.1k
  1. The spike protein of SARS-CoV — a target for vaccine and therapeutic development (2009)
    Lanying Du, Yuxian He et al. Nature Reviews Microbiology
  2. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine (2020)
    Wanbo Tai, Lei He et al. Cellular and Molecular Immunology
  3. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion (2020)
    Shuai Xia, Meiqin Liu et al. Cell Research
  4. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (2020)
    Shibo Jiang, Christopher D. Hillyer et al. Trends in Immunology
  5. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry (2019)
    Yushun Wan, Jian Shang et al. Journal of Virology
  6. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike (2019)
    Shuai Xia, Lei Yan et al. Science Advances
  7. Recent advances in the detection of respiratory virus infection in humans (2020)
    Naru Zhang, Lili Wang et al. Journal of Medical Virology
  8. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor (2014)
    Lu Lu, Qi Liu et al. Nature Communications

Immediate Impact

6 by Nobel laureates 31 from Science/Nature 174 standout
Sub-graph 1 of 12

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
De novo design of luciferases using deep learning
2023 StandoutNatureNobel
5 intermediate papers

Works of Lanying Du being referenced

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
2014
A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
2013
and 5 more

Author Peers

Author Last Decade Papers Cites
Lanying Du 10377 2748 2044 3021 180 13.7k
Yuxian He 8753 1855 1576 2313 149 11.6k
Susan C. Baker 9612 2878 1599 3417 135 15.5k
Jason S. McLellan 11473 1945 4804 4502 139 16.7k
Berend‐Jan Bosch 11483 4429 1576 2363 119 14.1k
Yusen Zhou 6547 1911 1466 2053 129 8.7k
Fang Li 15692 3805 1663 4073 145 20.3k
Linqi Zhang 10705 1204 3037 3434 225 17.8k
Lu Lu 6492 1031 1575 2984 297 11.4k
Raoul J. de Groot 8076 3409 1472 2400 96 12.0k
Kelvin Kai‐Wang To 11870 1306 4203 2457 314 18.3k

All Works

Loading papers...

Rankless by CCL
2026